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Abstract
Purpose To evaluate the association of shock-wave lithotripsy (SWL) for kidney stones and hypertension or diabetes.
Methods Patients with urolithiasis treated by SWL were retrospectively identified. To assess whether shock-wave applica-
tion to the kidney is associated with long-term adverse effects, patients after SWL for kidney stones were selected as the 
main group of interest. Patients treated with shock waves for distal ureter stones only were chosen as a comparison group. A 
questionnaire was sent to all patients to assess the prevalence of hypertension and diabetes. The Swiss Health Survey (SHS) 
dataset was used as an additional comparison group.
Results After a median follow-up of 13.7 years, the odds ratio (OR) to report hypertension [OR 1.30 (95% CI 1.10–1.95)] or 
diabetes [OR 1.54 (95% CI 1.21–1.97)] was significantly higher in patients treated with SWL compared to the SHS dataset. 
In comparison with the kidney group, participants in the SHS had a significantly lower OR to report hypertension at follow-
up [OR 0.79 (95% CI 0.65–0.95)], while the OR to report hypertension [1.16 (95% CI 0.79–1.70)] was not significantly 
different in the distal ureter group. For diabetes, a significantly lower [OR 0.60 (95% CI 0.46–0.78)] in the SHS group and a 
non-significantly lower [OR 0.68 (95% CI 0.38–1.22)] in the ureter group was noted compared to the kidney group.
Conclusion Compared to the SHS data set SWL was in general associated with hypertension and diabetes. However, no 
clear difference between patients after SWL to the kidney compared to SWL to the distal ureter was seen and thus the data 
do not support a causal relationship.
Keywords Kidney calculi · Lithotripsy · Treatment outcome · Adverse effects
Introduction
Since its introduction in the 1980s, extracorporeal shock-
wave lithotripsy (SWL) quickly became the standard therapy 
for urinary calculi [1, 2]. Short-term side effects of SWL are 
well known and include renal hematoma, infectious compli-
cations, “steinstrasse” and renal colic caused by remaining 
calculi [3–5]. The question has been raised, whether SWL 
causes long-term damage to the kidney or adjacent organs 
(e.g., pancreas) [6, 7]. In our recent systematic review, we 
identified only weak evidence regarding potential long-term 
adverse effects like hypertension or diabetes after SWL [8]. 
Nevertheless, significant long-term effects may influence 
clinical decision making, in particular when ureterorenos-
copy (URS) is available as an alternative first-line interven-
tion for the treatment of kidney stones < 20 mm [9, 10]. In 
this study, we aimed to analyze whether SWL applied to the 
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kidney is associated with a higher risk to develop hyperten-
sion or diabetes after long-term follow-up.
Patients and methods
All patients with urinary calculi treated by SWL at our ter-
tiary care center between 1993 and 2013 were retrospec-
tively identified. Two different lithotripters were used during 
the study period: From the start of the study until 09/2007, 
the ESWL treatments were performed on a Dornier DL50 
lithotripter (Dornier MedTech, Wessling, Germany). Sub-
sequently, a Dornier DLS II (Dornier MedTech, Wessling, 
Germany) was in operation from 09/2007 until the end of 
this study.
We hypothesized that the prevalence of hypertension and 
diabetes is increased in patients treated by SWL for kid-
ney stones compared to patients treated by SWL for distal 
ureteral stones (Fig. 1), due to direct damage from shock 
waves to the kidney (hypertension) or the adjacent pancreas 
(diabetes). To assess whether SWL applied to the kidney 
is associated with long-term complications, patients were 
divided in two groups: The first group of patients consisted 
of patients treated by SWL for kidney stones (kidney group). 
Patients with distal ureter stones treated by SWL served as 
a second group (control group) as the kidneys were not 
exposed to shock waves. Patients with SWL treatments for 
upper or middle ureter stones were excluded as kidneys, and 
the pancreas might have been exposed to shock waves to 
some extent. Subsequently, patients treated by SWL for both 
kidney and distal ureter stones were excluded as well. After 
chart review, the following perioperative parameters for each 
patient were noted: Age, gender, number of SWL sessions 
and total of shock waves per session per patient.
Next, the study questionnaire was sent by mail to all 
included patients listed in our clinic records as being alive 
in 2015. The study questionnaire included the following 
questions: current weight, height, previous treatments for 
urolithiasis, current medication, diagnosis of or counseling 
for hypertension or diabetes. If patients did not respond 
after 3 weeks, the questionnaire was sent by mail one more 
time. As a comparison group, the study questionnaire data 
were compared with the Swiss Health Survey (SHS) data 
set [11]. The SHS selects individuals from the Swiss per-
manent population, meaning Swiss citizens and foreigners 
with a legal work permit aged 15 years and older, living 
in a private household. In 2012, 21.597 (53.1%) of 41.008 
individuals participated in the survey. The survey included 
questions regarding the participants’ health state including 
hypertension and diabetes. Answers of the study question-
naire from patients with urinary calculi treated by SWL in 
the past (kidney and control group) were compared with 
each other, and additionally, the SHS data set served as a 
third comparison group.
Independent predictors of hypertension or diabetes at 
follow-up were identified by multivariable analysis using 
logistic regression using the following covariates: Age, 
gender, BMI, different patient/population groups (kidney 
group, distal ureter group and SHS) or number of shock 
waves to either the kidney or distal ureter. We first compared 
all patients who received an SWL treatment to the SHS data 
set. Second, we compared the three different groups to each 
other (model 1). Finally, we analyzed dose dependence 
between number of shock waves and the reported diagnosis 
of hypertension or diabetes at follow-up (model 2). The vari-
ables BMI and age were grouped into quartiles. Because of 
an interaction between age and gender for hypertension as 
outcome, the interaction term age (in quartiles)*gender was 
added to the model with hypertension as outcome.
The results for continuous normally distributed variables 
are expressed as means ± standard deviation (SD), and 
Fig. 1  Anatomical illustration of the shock-wave-exposed organs. In 
the current study the proportion of long-term adverse effects in the 
kidney stone group was compared with the proportion in the distal 
ureter stone group
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differences in patient characteristics between two groups 
were compared using Student’s unpaired t test. Continuous 
non-normally distributed variables are presented as median 
and interquartile ranges (IQR) and analyzed using the 
Mann–Whitney U test. The results for categorical variables 
are presented as percentage analyzed using Fisher’s exact 
test or Chi-square test, whenever appropriate. Odds ratios 
(ORs) with 95% confidence intervals (CI) were calculated. 
Statistical analysis was performed with IBM SPSS Statistics 
(Version 24.0, Armonk, New York, USA: IBM Corp.). All 
statistical tests were two-sided, and a p value of < 0.05 was 
considered significant.
Results
A total of 7108 patients were available for chart review. 
After review, 4335 (61%) patients did not meet the pre-
defined inclusion criteria (Fig. 2): No SWL treatment for 
urolithiasis (1874), SWL treatment to the proximal/middle 
ureter or for kidney and distal ureter stones (1850), unclear 
anatomical location of the stone (221), age > 85 years (175), 
no contact data (90), death (72), several exclusion criteria 
(63). Eventually, questionnaires were sent to 2773 patients 
of which we had to exclude 856 patients because of: invalid 
contact data (720), death (60) or external retreatment for 
proximal/middle ureter or for kidney and distal ureter stones 
(52). For the final analysis 764/2646 (29%), patient question-
naires were available after a median follow-up of 13.7 years. 
A total of 585/764 (77%) patient questionnaires belonged to 
the SWL treatment group for kidney stones (kidney group), 
whereas 179/764 (23%) patient questionnaires belonged to 
the SWL treatment group for distal ureter stones.
The kidney group, the distal ureter group and the SHS 
data set differed regarding age, BMI and gender distribu-
tion (Table 1). The prevalence of hypertension and diabetes 
at follow-up for the kidney group, ureter group and SHS 
data set were 47.5, 49.4 and 27.5% and 14.1, 11.9 and 4.9%, 
respectively.
A multivariable regression analysis adjusted for the sig-
nificant confounders age, gender and BMI was performed to 
compare the SHS population to urolithiasis patients treated 
with shock-wave therapy. The odds to report hypertension 
(OR 1.30, 95% CI 1.10–1.95, p < 0.001) after a mean follow-
up of 13.7 years was significantly higher in patients with at 
least one shock-wave treatment to any anatomical location. 
Furthermore, patients with at least one shock-wave treat-
ment showed significantly higher odds (OR 1.54, 95% CI 
1.21–1.97, p < 0.001) to report diabetes at follow-up.
To distinguish the effect regarding anatomical location 
another multivariable regression analysis adjusted for age, 
gender and BMI was performed. Compared to patients with 
shock waves to the kidneys (kidney group), participants in 
the SHS had a significantly lower OR to report hypertension 
Fig. 2  Participant flow diagram. 
Of 7108 patents who were 
selected for chart review and 
questionnaires were sent to 
2646 patents fulfilling all inclu-
sion and exclusion criteria. 
The final cohort included 764 
patients
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at follow-up [OR 0.78 (95% CI 0.65–0.95), p = 0.014], while 
patients with shock waves to the distal ureter had a simi-
lar OR of 1.16 (95% CI 0.79–1.70), p = 0.458) (Table 2, 
model 1). Compared to the SWL kidney group, the OR to 
report diabetes at follow-up was 0.60 (95% CI 0.46–0.78), 
p < 0.001) in the SHS data set and 0.68 (95% CI 0.38–1.22), 
p = 0.199) in the distal ureter group (Table 3, model 1). 
To test for a potential dose dependency for shock waves, 
a further multivariable regression analysis adjusted for 
age, gender and BMI to calculate the OR for increasing 
number of shock waves (per 1000 shock waves) was per-
formed (model 2). Compared to the SHS data set, the odds 
to report hypertension was significantly and incrementally 
higher after every 1000 shock waves applied to the kidneys 
[OR 1.05 (95% CI 1.01–1.09), p = 0.016] or in every 1000 
shock waves applied to the distal ureter [OR 1.09 (95% CI 
1.00–1.18, p = 0.049] (Table 2, model 2). Similarly, the OR 
to report diabetes at follow-up was significantly higher in 
patients with more shock waves applied to the kidneys [OR 
1.09 (95% CI 1.04–1.14), < 0.001] but not to the distal ureter 
[OR 1.00 (95% CI 0.88–1.13), p = 0.961] (Table 3, model 2).
Discussion
This study shows two important results: First, patients with 
urolithiasis treated by shock waves at any location were at 
a higher risk to develop hypertension and diabetes during 
follow-up. Second, the odds to report hypertension or diabe-
tes were not different in patients treated with shock waves for 
Table 1  Patient characteristics
BMI body mass index, NA not applicable, SW shock waves
Kidney stone Distal ureter Swiss Health Survey
Number of patients 585 179 21 597
Age at follow-up (mean, years) 62.4 ± 14.4 63.8 ± 13.8 48.2 ± 18.6
Follow-up time (mean, years) 14.3 ± 6.1 15.7 ± 5.5 NA
BMI (mean, kg/m2) 26.3 ± 4.2 26.2 ± 4.1 24.6 ± 4.4
Gender (% female) 34.2 27.9 52.4
Number of SWL sessions (median) 1.0 [1, 2] 1.0 [1] NA
SW applied (median) 3000 [3000–6000] 4000 [3000–4000] NA
Arterial hypertension 47.5% 49.4% 27.5%
Diabetes mellitus 14.1% 11.9% 4.9%
Table 2  Multivariable logistic regression analysis of prevalence of hypertension at follow-up
BMI body mass index, SW shock waves
Model 1 Model 2
Hypertension OR (95% CI) p value Hypertension OR (95% CI) p value
Gender (male vs. female) 0.92 (0.78–1.10) 0.37 Gender (male vs. female) 0.92 (0.77–1.01) 0.371
Age < 0.001 Age < 0.001
1st quartile Reference 1st quartile Reference
2nd quartile 2.08 (1.45–2.94) < 0.001 2nd quartile 2.09 (1.48–2.95) < 0.001
3rd quartile 4.47 (3.24–6.16) < 0.001 3rd quartile 4.48 (3.25–6.17) < 0.001
4th quartile 6.23 (4.51–8.56) < 0.001 4th quartile 6.29 (4.56–8.67) < 0.001
BMI < 0.001 BMI < 0.001
1st quartile Reference 1st quartile Reference
2nd quartile 1.51 (1.36–1.69) < 0.001 2nd quartile 1.51 (1.36–1.69) < 0.001
3rd quartile 2.20 (2.00–2.44) < 0.001 3rd quartile 2.20 (1.97–2.44) < 0.001
4th quartile 4.33 (3.90–4.81) < 0.001 4th quartile 4.33 (3.90–4.80) < 0.001
Anatomical location < 0.001
SW to the kidney Reference
No SW 0.79 (0.65–0.95) 0.014
SW to the distal ureter 1.16 (0.79–1.70) 0.458
Per 1000 SW to the kidney 1.05 (1.01–1.09) 0.016
Per 1000 SW to the distal ureter 1.09 (1.00–1.18) 0.049
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kidney stones compared to patients treated for distal ureter 
stones by SWL.
Regarding the first result, our multivariable regression 
analysis adjusted for known confounders confirmed that 
patients with urinary calculi are at a higher risk for long-
term adverse effects including arterial hypertension [12–14] 
and diabetes mellitus [15]. Therefore, studies observing 
potential long-term adverse effects of stone treatment should 
ideally compare patients with urinary calculi with or without 
treatment and not patients treated with urinary calculi com-
pared to the general population. Otherwise, two conditions 
including the underlying metabolic dysfunction as well as 
the SWL treatment will be responsible for the higher preva-
lence of hypertension or diabetes.
Regarding the second result, patients after SWL to the 
kidney showed similar odds to report hypertension or dia-
betes compared to patients after SWL to the distal ureter. 
Patients who had shock waves to the distal ureter were 
chosen as the main comparison group within SWL treated 
patients, as the distal ureter is as most far afield to the kid-
neys and pancreas and thus both organs were not exposed to 
shock waves in the distal ureter group. Taken together, our 
data do not support the hypothesis that SWL to the kidneys 
leads to a higher odds to report hypertension or diabetes 
after long-term follow-up. Our present findings are in line 
with our recent systematic review, in which the evidence for 
SWL causing hypertension or diabetes was weak [8].
Since our review in 2013, two further systematic reviews 
including the same studies [16, 17] and two cohort studies 
have been published. The first systematic review looked at 
new-onset diabetes after SWL for urinary stones and con-
cluded that there is no association between SWL and new-
onset diabetes [16]. The second review focused on long-term 
renal functions after SWL in the pediatric population and 
concluded that there is no evidence suggesting long-term 
damage [17]. The first cohort study by Pirola included 100 
patients treated by SWL and found that creatinine values 
remained unchanged and the prevalence of diabetes and 
hypertension seems to be similar to the general population 
[18]. However, this study compared a SWL cohort of kid-
ney stone patients with the general population. This limits 
its interpretation as patients with urolithiasis are in general 
at a higher risk to develop hypertension and diabetes dur-
ing follow-up as discussed above. The second retrospec-
tive study by Denburg et al. [19] included 1319 patients 
treated by SWL with a follow-up of less than 4 years. They 
found that SWL was associated with a significant increased 
risk of hypertension. When they further stratified if SWL 
was applied to the kidney or ureter, only SWL to the kid-
ney was significantly and independently associated with 
hypertension.
The result of our study and that of von Denburg have to 
be interpreted in the context of the study design. A major 
confounding variable may represent stone burden differ-
ences in the kidney and ureter group. In both studies, it 
was not possible to account for number and size of kidney 
stones. Therefore, patients with more and/or larger stones 
due to worse metabolic disease are more likely to be in the 
Table 3  Multivariable logistic regression analysis of prevalence of diabetes at follow-up
BMI body mass index, SW shock waves
Model 1 Model 2
Diabetes OR (95% CI) p value Diabetes OR (95% CI) p value
Gender (male vs. female) 1.81 (1.04–3.15) 0.035 Gender (male vs. female) 1.81 (1.04–3.15) 0.035
Age < 0.001 Age < 0.001
1st quartile Reference 1st quartile Reference
2nd quartile 4.72 (1.62–13.74) 0.004 2nd quartile 4.75 (1.63–13.85) 0.004
3rd quartile 19.18 (7.14–51.53) < 0.01 3rd quartile 19.27 (7.17–51.76) < 0.001
4th quartile 44.26 (16.87–116.10) 4th quartile 45.50 (17.37–119.40) < 0.001
BMI < 0.001 BMI < 0.001
1st quartile Reference 1st quartile Reference
2nd quartile 1.27 (0.97–1.66) 0.78 2nd quartile 1.27 (0.97–1.66) 0.079
3rd quartile 1.68 (1.31–2.17) < 0.001 3rd quartile 1.69 (1.32–2.18) < 0.001
4th quartile 4.46 (3.54–5.62) 4th quartile 4.46 (3.54–5.62) < 0.001
Anatomical location < 0.001
SW to the kidney Reference
No SW 0.60 (0.46–0.78) < 0.001
SW to the distal ureter 0.68 (0.38–1.22) 0.199
Per 1000 SW to the kidney 1.09 (1.04–1.14) < 0.001
Per 1000 SW to the distal ureter 1.00 (0.88–1.13) 0.961
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kidney stone group, which represent a possible confounder. 
We found that patients with an increasing number of shock 
waves (per 1000 shock waves) to the kidney were more 
likely to report hypertension or diabetes at follow-up. The 
observed dose dependence raises the question whether this 
association is causal. However, recurring treatment is more 
likely needed in patients with underlying metabolic dysfunc-
tion causing recurrent stone formation which again might be 
an important confounder.
Limitations of our study are the moderate questionnaire 
response rate and the unavailable information regarding 
hypertension or diabetes at time-point of SWL. Additionally, 
currently used lithotripter, newer settings (e.g., ramping [20, 
21]) and co-current medications [22] have been discussed to 
reduce damage to the kidneys but were not used in this study. 
Nevertheless, in the absence of prospective data from larger 
cohorts with an appropriate follow-up, our study is a unique 
and valuable opportunity to study long-term adverse effects. 
Furthermore, our medical chart review minimizes the mis-
classification bias as no automatic code extraction was used.
Conclusion
In conclusion, we recommend that physicians should not 
only counsel patients with urinary calculi regarding stone 
metaphylaxis but also regarding their increased risk to 
develop hypertension and diabetes. According to our data, 
SWL seems to be a safe procedure and there are no or only 
minimal long-term adverse effects like hypertension or 
diabetes.
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